![](/img/cover-not-exists.png)
P724 Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data
Card, T, Ungaro, R, Bhayat, F, Blake, A, Hantsbarger, G, Travis, SVolume:
13
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjy222.848
Date:
January, 2019
File:
PDF, 1.38 MB
english, 2019